Drugs / 3D-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04661644 | Nov 2020 → Apr 2024 | limb ischemia | S.Biomedics Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3D-A | “the investigational product(A cluster of adipose-derived mesenchymal stem cells (3D-A) (cluster of adipose- derived mesenchymal stem cells)) and proceeds in that order.” NCT04661644 ↗ |
| Modality | Cell therapy | “Clusters of adipose-derived mesenchymal stem cells” NCT04661644 ↗ |
| Route | Intramuscular | “administered in 20 divided doses to 15-20 parts of the muscle” NCT04661644 ↗ |